Showing results (531-540 of 777) with videos related to
Sort By:
Pageof 78
The Journal of Urology|August 19, 2007
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomyAhmed Magheli, Soroush Rais-Bahrami, Hugh J Peck, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2026
Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation FrameworkKevin M Koo, Grant Phillips, Sriganesh Srihari, et al.Urology|January 18, 2006
Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostateMark L Gonzalgo, Patrick J Bastian, Leslie A Mangold, et al.The American Journal of Surgical Pathology|August 27, 2016
TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic HeterogeneityPedram Argani, Victor E Reuter, Lei Zhang, et al.BJU International|March 8, 2013
Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillanceJeffrey K Mullins, David Bonekamp, Patricia Landis, et al.Human Pathology|July 23, 2011
Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic centerThomas K Lee, Alcides Chaux, Sarah Karram, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|July 11, 2019
Extramammary Paget Disease of the Scrotum: A Contemporary Clinicopathologic Analysis of 20 Cases in the United StatesMaryam Shabihkhani, Pallavi Patil, Belkiss Murati Amador, et al.Histopathology|October 10, 2019
SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumoursDeepthi Hoskoppal, Jonathan I Epstein, Allen M Gown, et al.Journal of the National Cancer Institute|November 2, 2006
Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curabilityH Ballentine Carter, Luigi Ferrucci, Anna Kettermann, et al.The Journal of Urology|July 4, 2006
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/mlDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.Pageof 78